Ress Uncorrelated Assets Fund provides portfolio composition update

September 16, 2016
Published: 2016-09-16 17:11:40 CEST

Ress Life Investments A/S
Holbergsgade 14, 2 tv
DK-1057 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 16 September 2016

Corporate Announcement 29/2016

Ress Uncorrelated Assets Fund provides portfolio composition update

Ress Life Investments A/S acts as a feeder and invests in fund units of the master fund, Ress Uncorrelated Assets Fund. The AIF-manager of the master fund has provided the following information.

As of 31 August, the portfolio of the master fund included 206 policies with a total face value of USD 407 930 825. Below is a breakdown of the portfolio composition along different categories.

Top Carriers Weight%
John Hancock Life Insurance Company USA 14.9%
AXA Equitable Life Insurance Company 8.4%
Lincoln National Life Insurance Company 8.1%
Transamerica Life Insurance Company 6.2%
Protective Life Insurance Company 5.9%
MetLife Insurance Company USA 5.0%
Security Life Of Denver Insurance Company 4.1%
C.M. Life Insurance Company 3.9%
Lincoln Benefit Life Insurance Company 3.8%
American General Life Insurance Company 3.7%
Age Group Weight%
<65 0.1%
65-69 3.3%
70-74 22.0%
75-79 39.3%
80-84 24.1%
85-89 10.7%
90-94 0.6%

Carrier Rating Weight%
A++ 6.4%
A+ 70.4%
A 12.6%
A- 10.5%
Top States Weight%
FL 16.6%
CA 15.8%
NY 10.7%
TX 5.3%
IL 4.0%
NJ 2.9%
NC 1.9%
TN 1.2%
WA 0.4%
OK 0.1%

Gender Weight%
Female 29.4%
Male 70.6%

Mortality Rating/Multiplier Weight%
<100 25.8%
100-150 47.5%
150-200 13.5%
200-250 3.3%
250-300 3.2%
300-350 1.8%
350-400 2.6%
400- 2.3%

BMI Group Weight%
Underweight 1.8%
Normal 30.6%
Overweight 37.5%
Obese Class I 20.2%
Obese Class II 7.4%
Obese Class III 2.5%

Blood pressure Weight%
Hypotension 7.6%
Normal 15.2%
Prehypertension 52.1%
Stage 1 Hypertension 21.5%
Stage 2 Hypertension 3.5%

Life Expectancy Weight%
< 2 0.1%
2-3 0.6%
4-5 2.5%
6-7 9.1%
8-9 20.8%
10-11 33.2%
12-15 22.3%
16- 11.5%

Impairment Category Weight%
Endocrine/Metabolic 21.5%
Gastro Intestinal 14.2%
Cardiac 13.6%
Musculoskeletal 10.8%
Genito-Urinary 5.9%
Dermatologic Cond. 5.6%
ENT 5.3%
Ophthalmologic Diseases 4.4%
Pulmonary 4.3%
Hematology 3.0%
Psychiatric Disorders 2.7%
Renal 1.8%
Oncology 1.7%
Cerebro-Vascular 1.6%
Neurology 1.2%
Vascular Disorders 0.7%
Infectious Disease 0.7%
Miscellaneous 0.5%
Gynecological Cond. 0.3%
Psychiatric 0.2%
Rheumatologic/Immuno 0.1%

Category Sub-category breakdown Weight%
Endocrine/Metabolic Dyslipidemia — Lipid Profile 12.7%
Cardiac Hypertension(HTN) — Controlled HTN 8.7%
Endocrine/Metabolic Diabetes Mellitus — Type 2 Diabetes Mellitus 4.6%
Musculoskeletal Bone Density — Osteopenia 3.8%
Ophthalmologic Diseases Cataracts 3.5%
Endocrine/Metabolic Thyroid Disease — Hypothyroidism 3.3%
Gastro Intestinal Polyps — Colon polyps 2.6%
Genito-Urinary ED 2.3%
Dermatologic Cond. Squamous Cell Carcinoma 2.2%
Dermatologic Cond. Keratosis — Actinic Keratosis 2.1%
Cardiac Atrial Fibrillation — A-Fib Considered 1.8%
Psychiatric Disorders Depression — Depression (Mild/Unspecified) 1.8%
ENT Allergy — Allergic rhinitis 1.6%
Gastro Intestinal Hemorrhoids — Internal Hemorrhoids 1.3%
Pulmonary Sleep Apnea 1.3%
Ophthalmologic Diseases Glaucoma 0.9%
Endocrine/Metabolic Gout 0.8%
Oncology Prostate Cancer — Grade 2: Gleason 5-7 0.6%
Gastro Intestinal Liver — Fatty Liver 0.6%
Cerebro-Vascular Carotid Disease 0.5%
Cerebro-Vascular Stroke/CVA 0.5%
ENT Ear Disorders (Vestibulo-Cochlear) 0.4%
Pulmonary URI 0.4%
Gastro Intestinal Ulcerative Colitis 0.1%
Gastro Intestinal GERD — Mild GERD 0.1%
Pulmonary COPD — Symptoms of COPD 0.1%
Oncology Colon/Rectal Cancer 0.1%
Rheumatologic/Immuno Rheumatoid Arthritis 0.1%
Ophthalmologic Diseases Macular Degeneration 0.1%
Gastro Intestinal Polyps — Polypectomy 0.1%

Questions related to this announcement can be made to the company’s AIF-manager, Resscapital AB.

Contact person:
Jonas Mårtenson
jonas.martenson@resscapital.com
Tel + 46 8545282 09


Ress Life Investments AS – Company Announcement 29-2016.pdf